InvestorsHub Logo
Followers 155
Posts 2647
Boards Moderated 0
Alias Born 01/29/2004

Re: Bud Powell post# 69929

Monday, 07/25/2016 3:28:48 PM

Monday, July 25, 2016 3:28:48 PM

Post# of 462643
Bud,

I thank you for your comment.

I’m a biologist. I understand the essentials of the unique biochemistry of 2-73 and cellular physiology. I’m not any sort of investment guru, and have no comments (even interest in) the many chart and trends postings here. Plenty of experts on those topics. (But, of course, I do hold a number of AVXL shares, and don’t intend to reap any profits for several years, when appreciation will have added one or two digits to the share price.)

But the molecular and cellular functions of Anavex drugs are far more complicated than the multi-colored share price charts so frequently posted (and, by me, misunderstood). I’m a retired biology teacher, with a certain ability to present complicated biological concepts to interested audiences, whether to students interested for a good grade, or, here, for audiences trying to do due diligence on the arcane topics of neurological drugs.

With Anavex, we have a winner.

Glad to be of some help.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News